Laserfiche WebLink
EXFOXNET PIP-E5FE•NVALERATE htip:/iace.orst.cdu/cgi-bin/mis/ol/pips/csfenval.htm <br /> i in the two products are the relative proportions of the four separate constituents (isomers). Esfenvalerate <br /> has become the preferred compound because it requires lower applications rates than fenvalerate, is less <br /> chronically toxic, and is a more powerful insecticide. The compound contains a much higher percentage <br /> of the one insecticidally active isomer(84% for esfenvalerate and 22% for fenvalerate). <br /> Toxicological Effects: <br /> 4 <br /> • Acute toxicity: Esfenvalerate is a moderately toxic compound via the oral route. The reported oral <br /> LD50 of esfenvalerate is 458 mg/kg in rats. It is slightly toxic via the dermal route, with a reported <br /> dermal LD50 of 2500 mg/kg in rabbits. It is practically non-toxic via inhalation, with a reported <br /> inhalation LC50 of greater than 2.93 mg/L in rats [2,12]. Because esfenvalerate is a relatively new <br /> compound it has little usage history. The bulk of evidence related to acute poisonings in humans <br /> due to esfenvalerate comes from incidents in India. Nearly 600 individual cases of poisoning were <br /> reported between 1982 and 1988. These cases were due to improper handling of the pesticide. <br /> Acute toxic effects were observed in workers and among the general public. Symptoms of acute <br /> poisoning included dizziness, burning and itching (which was worsened by sweating and washing). <br /> r Severe cases of direct contact caused blurred vision, tightness in the chest, and convulsions (2). The <br /> changes appear to be reversible. In rats, high acute exposure to esfenvalerate produced muscle <br /> incoordination, tremors, convulsions, nerve damage, and weight loss. The compound may produce <br /> nausea, vomiting, headache, temporary nervous system effects such as weakness, tremors, and <br /> incoordination at acute exposure levels in humans. Esfenvalerate is a strong eye irritant, producing <br /> tearing or blurring of vision. i <br /> • Chronic toxicity: Rats fed fenvalerate at concentrations of approximately 12.5 mg/kg/day for two <br /> f years had no compound-related changes in the blood or urine [12]. In other studies significant <br /> ► reduction in body weight was the main adverse effect seen in both rats and mice of both sexes. <br /> • Reproductive effects: In a three-generation rat study, low doses (up to 12.5 mg/kg/day) of <br /> fenvalerate produced no toxicity in the fetus. Some maternal toxicity was noted in the second <br /> generation at the higher dose. When pregnant mice and rabbits were fed low dietary levels of <br /> i fenvalerate (2.5 mg/kg/day) on days_ 6 to 15 of gestation, there was maternal toxicity in both species. <br /> It seems that during pregnancy, the females are more sensitive to fenvalerate than they would <br /> -otherwise be, even though the toxicity is not reflected in any effect on the fetus [5]. There are no <br /> specific data available for esfenvalerate, but it is not expected to cause reproductive effects at low <br /> i doses. <br /> i Teratogenic effects: Esfenvalerate did not produce any birth defects in offspring at low dietary <br /> doses [2]. It appears the the pesticide would not pose a teratogenic threat to humans at expected <br /> exposure levels. <br /> • Mutagenic effects: Esfenvalerate shows no mutagenic effects. Numerous tests in hamsters, mice <br /> and rats show no signs of mutagenic activity associated with this compound [2]. It is likely that it <br /> poses no mutagenic risk to humans. <br /> • Carcinogenic effects: A rat study of fenvalerate conducted over a wide range of doses of up to 75 <br /> mg/kg, for two years, resulted in no evidence of cancer. Mice fed diets containing small amounts of <br /> fenvalerate for two years showed no adverse effects [2]. It appears that fenvalerate does not cause <br /> cancer. <br /> • Organ toxicity: Studies to date have not shown any dose-related effects on internal organs of test h <br /> animals or in human populations [2]. <br /> • Fate in humans and animals: Cows treated with 0.1 or 0.5 g fenvalerate on their skin had 0.03 to <br /> 0.06% of the applied chemical in the milk. When the cows received fenvalerate orally at very low <br /> levels, about 0.50% of the dose appeared in the milk. Fenvalerate does not appear to be metabolized <br /> by bovine rumen, but it is degraded further down the digestive tract [32]. This happens rapidly with <br /> )f 1/26/00 8:59 Adel <br />